alexa Abstract | Impaired Bioavailability Of Rifampicin From Fixed Dose Combination (FDC) Formulations With Isoniazid

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access

Abstract

Antitubercular Fixed Dose Combinations (FDCs) containing rifampicin (RIF) along with Isoniazid (INH), And/or pyrazinamide (PZ) and/or ethambutol (ETB) ensure better patient compliance and help to minimize development of resistance to the drugs by M. tuberculosis. However, poor bioavailability of RIF In these FDC formulations is a subject of much concern for the last three decades. Poor bioavailability of RIF could lead to faulty treatment and to the drug resistance. WHO and IUATLD have now sounded a caution that antitubercular FDC formulations should be used only if the bioavailability of RIF has been demonstrated convincingly. It has been suggested that probable physical factors responsible for the variable bioavailability of RIF include particle size, crystalline nature, nature of excipients and lack of GMP. However, nine of these explanations are found to be satisfactory. During the last few years, sufficient data has been generated, independently, in two Indian research laboratories, indicating that in the acidic medium of the stomach, RIF degrades to form an insoluble and inactive 3-formyl rifamycin SV, an aldehyde, involving a distinct catalytic role of INH. An elegant reaction mechanism has been proposed for the impaired bioavailability of RIF from FDC formulations containing INH. With a better understanding of the interaction of RIF and INH in the acidic medium, it should now be possible to formulate a stable FDC with acceptable and reproducible bioavailability of RIF.

To read the full article Peer-reviewed Article PDF image

Author(s): C J Shishoo S A Shah I S Rathod S S Savale

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords